Tower Research Capital LLC TRC Decreases Stake in Sotera Health (NASDAQ:SHC)

Tower Research Capital LLC TRC reduced its stake in Sotera Health (NASDAQ:SHC) by 51.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,435 shares of the company’s stock after selling 6,924 shares during the period. Tower Research Capital LLC TRC’s holdings in Sotera Health were worth $108,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of SHC. Bleakley Financial Group LLC increased its stake in shares of Sotera Health by 7.3% during the second quarter. Bleakley Financial Group LLC now owns 12,509 shares of the company’s stock valued at $236,000 after buying an additional 851 shares during the period. Sei Investments Co. increased its stake in shares of Sotera Health by 2.2% during the fourth quarter. Sei Investments Co. now owns 39,645 shares of the company’s stock valued at $330,000 after buying an additional 851 shares during the period. Public Employees Retirement System of Ohio increased its stake in shares of Sotera Health by 2.1% during the fourth quarter. Public Employees Retirement System of Ohio now owns 50,660 shares of the company’s stock valued at $422,000 after buying an additional 1,062 shares during the period. Lazard Asset Management LLC increased its stake in shares of Sotera Health by 14.0% during the fourth quarter. Lazard Asset Management LLC now owns 9,908 shares of the company’s stock valued at $82,000 after buying an additional 1,217 shares during the period. Finally, Victory Capital Management Inc. increased its stake in shares of Sotera Health by 6.1% during the fourth quarter. Victory Capital Management Inc. now owns 21,635 shares of the company’s stock valued at $180,000 after buying an additional 1,247 shares during the period. 91.03% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on SHC shares. Royal Bank of Canada restated an “outperform” rating and set a $20.00 price target on shares of Sotera Health in a research report on Monday, March 4th. KeyCorp assumed coverage on Sotera Health in a research report on Tuesday, February 6th. They set a “sector weight” rating on the stock. Barclays boosted their target price on Sotera Health from $17.00 to $19.00 and gave the stock an “overweight” rating in a report on Wednesday, February 28th. Citigroup raised Sotera Health from a “neutral” rating to a “buy” rating and dropped their target price for the stock from $18.00 to $16.00 in a report on Wednesday. Finally, Jefferies Financial Group upgraded Sotera Health from a “hold” rating to a “buy” rating and boosted their price target for the stock from $15.00 to $15.50 in a research note on Monday, March 25th. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $18.70.

Sotera Health Stock Performance

SHC traded down $0.06 during midday trading on Friday, reaching $11.34. The company had a trading volume of 1,190,554 shares, compared to its average volume of 2,079,613. The company has a quick ratio of 2.21, a current ratio of 2.42 and a debt-to-equity ratio of 5.16. The business has a 50-day moving average of $14.33 and a two-hundred day moving average of $14.48. The company has a market cap of $3.21 billion, a P/E ratio of 63.00 and a beta of 2.11. Sotera Health has a 1 year low of $10.74 and a 1 year high of $19.40.

Sotera Health (NASDAQ:SHC) last issued its earnings results on Tuesday, February 27th. The company reported $0.26 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.26. The company had revenue of $310.24 million for the quarter, compared to the consensus estimate of $302.17 million. Sotera Health had a return on equity of 51.32% and a net margin of 4.90%. The firm’s quarterly revenue was up 23.3% on a year-over-year basis. During the same quarter last year, the company earned $0.23 EPS. As a group, equities research analysts predict that Sotera Health will post 0.64 earnings per share for the current fiscal year.

Insider Activity at Sotera Health

In related news, insider Michael P. Rutz sold 83,109 shares of Sotera Health stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $14.31, for a total transaction of $1,189,289.79. Following the sale, the insider now owns 544,409 shares of the company’s stock, valued at approximately $7,790,492.79. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Sotera Health news, insider Michael P. Rutz sold 83,109 shares of the firm’s stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $14.31, for a total transaction of $1,189,289.79. Following the completion of the transaction, the insider now owns 544,409 shares in the company, valued at approximately $7,790,492.79. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Pincus & Co. Warburg sold 16,594,363 shares of the firm’s stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $14.31, for a total value of $237,465,334.53. Following the transaction, the director now owns 88,822,952 shares of the company’s stock, valued at approximately $1,271,056,443.12. The disclosure for this sale can be found here. 65.13% of the stock is owned by corporate insiders.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.